New COVID-19 test funded by NBA, NBPA gets FDA approval

By Erin Walsh | Last updated 8/15/20

The NBA and NBPA funded the development of a saliva-based COVID-19 test by Yale University, and now there’s been a breakthrough in its development. 

According to ESPN’s Zach Lowe, the U.S. Food and Drug Administration issued emergency authorization for public use of the test known as SalivaDirect. 

SalivaDirect is designed for widespread public coronavirus screening, and Lowe explains that it’ll likely cost consumers between $15-$20. 

To continue reading the full article, click HERE.

Leave a Reply

Your email address will not be published. Required fields are marked *